S. Alkner

发表

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.

M. Fernö, P. Bendahl, L. Rydén, 2009, European journal of cancer.

AIB1 is a predictive factor for tamoxifen response in premenopausal women.

M. Fernö, K. Lövgren, P. Bendahl, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer

M. Fernö, A. Ehinger, K. Lövgren, 2016, PloS one.

Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.

M. Fernö, A. Ehinger, P. Bendahl, 2015, European journal of cancer.

Prediction of outcome after diagnosis of metachronous contralateral breast cancer

M. Fernö, P. Bendahl, L. Rydén, 2011, BMC Cancer.

Surface guided radiotherapy (SGRT) improves breast cancer patient setup accuracy

F. Mahmood, C. Behrens, S. Ceberg, 2019, Journal of applied clinical medical physics.

Pelvic U-Net: multi-label semantic segmentation of pelvic organs at risk for radiation therapy anal cancer patients using a deeply supervised shuffle attention convolutional neural network

P. Munck Af Rosenschöld, L. Olsson, J. Scherman, 2022, Radiation oncology.

Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer

A. Ehinger, L. Hartman, A. Jögi, 2019, PloS one.

Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer

K. Czene, P. Hall, H. Adami, 2013, International journal of cancer.

Distribution of locoregional breast cancer recurrence in relation to postoperative radiation fields and biological subtypes.

F. Killander, E. Holmberg, P. Karlsson, 2019, International journal of radiation oncology, biology, physics.

T1-mapping and OE-MRI of patients treated with radiotherapy for breast cancer

J. Svensson, P. Wollmer, P. Nilsson, 2015 .

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98

M. Fernö, H. Mouridsen, L. Rydén, 2017, Breast Cancer Research and Treatment.

Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy

J. Medin, L. Olsson, S. Alkner, 2022, Frontiers in Oncology.

Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing

L. Saal, M. Fernö, A. Ehinger, 2015, Breast Cancer Research.

The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

M. Fernö, L. Rydén, D. Grabau, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Predicting Prognosis and Tamoxifen Response in Breast Cancer. With a special focus on contralateral breast cancer.

S. Alkner, 2012 .

Stability of oestrogen and progesterone receptor antigenicity in formalin‐fixed paraffin‐embedded breast cancer tissue over time

M. Fernö, A. Ehinger, P. Bendahl, 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial

L. Rydén, Y. Wengström, P. Christiansen, 2022, Breast.

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer

M. Fernö, P. Bendahl, L. Rydén, 2020, PloS one.

Clinical validation of a commercially available deep learning software for synthetic CT generation for brain

J. Medin, L. Olsson, C. Siversson, 2021, Radiation oncology.

Dosimetric effects of intrafractional isocenter variation during deep inspiration breath‐hold for breast cancer patients using surface‐guided radiotherapy

S. Ceberg, S. Alkner, A. Edvardsson, 2017, Journal of applied clinical medical physics.

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast

M. Fernö, K. Lövgren, C. Ingvar, 2019, Breast Cancer Research and Treatment.

Comparative treatment planning study for mediastinal Hodgkin’s lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy

S. Engelholm, E. Kjellén, S. Ceberg, 2018, Acta oncologica.

Abstract P4-09-07: Prediction of Outcome after Diagnosis of Metachronous Contralateral Breast Cancer

M. Fernö, P. Bendahl, L. Rydén, 2010 .

Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis.

C. Isacke, H. Rugo, L. Livi, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases – an open, multicentre, randomised non-inferiority phase 3 trial

P. Bendahl, L. Rydén, I. Mjaaland, 2023, BMJ Open.

Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial.

T. Reimer, R. Szulkin, D. Lundstedt, 2024, The Lancet. Oncology.

Quality assessment of radiotherapy in the prospective randomized SENOMAC trial.

T. Reimer, E. Wieslander, J. de Boniface, 2024, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.